Sperimentazione in fase di reclutamento = ; Sperimentazione in corso = ; Finanziato da un ente associato a IRDiRC = ; Membro di una ERN =

Sperimentazioni cliniche nazionali

AUSTRIA

WIEN
ADDRESS: NOT PROVIDED - AT

A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of Mavorixafor in Patients With WHIM Syndrome With Open-Label Extension - AT

Institution: Information not provided - AT

Ulteriori dettagli

BELGIO

ARRONDISSEMENT BRUSSELS-CAPITAL
BRUSSELS

GLYCO-1B: Evaluation of the Safety and Efficacy of Empagliflozin Administration as a Treatment for Neutropenia in Patients With Glycogenosis Type 1b and G6PC3 Deficiency

Cliniques universitaires Saint-Luc - UCLouvain

Cliniques Universitaires Saint-Luc

Ulteriori dettagli

SPAGNA

Madrid
ADDRESS: NOT PROVIDED - ES

A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of Mavorixafor in Patients With WHIM Syndrome With Open-Label Extension - ES

Institution: Information not provided - ES

Ulteriori dettagli

STATI UNITI

California
WESTLAKE VILLAGE

Post-Authorization Safety, Tolerability and Immunogenicity Evaluation of HyQvia in Pediatric Subjects with Primary Immunodeficiency Diseases -GB

Baxalta US, Inc.

Ulteriori dettagli